← All stocks

Atea Pharmaceuticals, Inc.

AVIR Net buying
CIK 0001593899 #3209 in the set updated 21 Sep 2026
Bought (120 mo)
$13.21M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$2.03M
$457.00K on a plan · $0.00 straight out of an exercise
Sold at will
$1.57M
9 of 14 sales
Net
+$11.18M
+$11.64M against sales at will

By person

16 insiders · 24 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Hack Andrew A. F.
Director
$6.00M (1)
+$6.00M
5,615,659
7.00%
$23.43M
Rock Springs Capital Management LP entity
10% owner
$6.00M (2)
+$6.00M
289,695
0.3612%
$1.21M
Sommadossi Jean-Pierre
President, CEO, and Chairman
$457.00K (5) scheduled
−$457.00K
12,558,855
15.66%
$52.39M
+13.1%
BERGER FRANKLIN M
Director
$1.08M (3)
$1.24M (3)
−$156.68K
536,097
0.6684%
$2.24M
+679.8%
Murphy Polly A.
Director
$128.24K (2)
+$128.24K
133,040
0.1659%
$554.98K
+1,078%
Polsky Bruce
Director
$61.14K (1)
−$61.14K
124,806
0.1556%
$520.63K
+149.6%
Horga Maria Arantxa
Chief Medical Officer
$60.96K (1)
−$60.96K
96,086
0.1198%
$400.82K
Corcoran Andrea
See Remarks
$60.91K (1)
−$60.91K
823,576
1.03%
$3.44M
+57.0%
Hammond Janet MJ
Chief Development Officer
$53.91K (1)
−$53.91K
127,665
0.1592%
$532.55K
+1,707%
Foster Wayne
EVP, Chief Accounting Officer
$47.90K (1)
−$47.90K
79,329
0.0989%
$330.92K
Vavricka John
Chief Commercial Officer
$45.42K (1)
−$45.42K
165,102
0.2059%
$688.72K
Cormorant Asset Management, LP entity
Former 10% Owner
6,411,355
7.99%
$26.74M
Chu Chung K.
10% owner
1,176,862
1.47%
$4.91M
+17.7%
Lucidi Bruno
Director
142,350
0.1775%
$593.81K
+184.7%
DUNCAN BARBARA GAYLE
Director
92,350
0.1151%
$385.24K
Adams Jerome M.
Director
92,350
0.1151%
$385.24K
Insider
Date
Role
Action
Shares
Price
Amount
Corcoran Andrea
11 Mar 2026
See Remarks
Exercised, kept
60,000
$1.24
$74.40K
Sommadossi Jean-Pierre
3 Feb 2026
President, CEO, and Chairman
Exercised, kept
300,000
$1.24
$372.00K
Murphy Polly A.
18 May 2025
Director
Buy
6,100
$4.17
$25.45K
BERGER FRANKLIN M
16 Jan 2025
Director
Buy
10,000
$3.36
$33.61K
BERGER FRANKLIN M
15 Jan 2025
Director
Buy
15,000
$3.19
$47.88K
BERGER FRANKLIN M
10 Dec 2024
Director
Sell
359,606
$2.85
$1.02M
Sommadossi Jean-Pierre
19 Sep 2024
President, CEO, and Chairman
Sold on a plan indirect
1,841
$4.00
$7.37K
Sommadossi Jean-Pierre
18 Sep 2024
President, CEO, and Chairman
Sold on a plan indirect
22,187
$4.03
$89.47K
Sommadossi Jean-Pierre
17 Sep 2024
President, CEO, and Chairman
Sold on a plan indirect
33,941
$4.05
$137.32K
Polsky Bruce
20 Jun 2024
Director
Sell
17,544
$3.49
$61.14K
Sommadossi Jean-Pierre
5 Jun 2024
President, CEO, and Chairman
Sold on a plan indirect
1,006
$4.00
$4.02K
Hammond Janet MJ
1 Feb 2024
Chief Development Officer
Sell
14,029
$3.84
$53.91K
Vavricka John
1 Feb 2024
Chief Commercial Officer
Sell
11,819
$3.84
$45.42K
Foster Wayne
1 Feb 2024
EVP, Chief Accounting Officer
Sell
12,477
$3.84
$47.90K
Horga Maria Arantxa
1 Feb 2024
Chief Medical Officer
Sell
15,870
$3.84
$60.96K
Sommadossi Jean-Pierre
1 Feb 2024
President, CEO, and Chairman
Sold on a plan
56,910
$3.85
$218.82K
Corcoran Andrea
1 Feb 2024
See Remarks
Sell
15,843
$3.84
$60.91K
BERGER FRANKLIN M
14 Nov 2022
Director
Sell
16,166
$5.16
$83.35K
BERGER FRANKLIN M
11 Nov 2022
Director
Sell
25,500
$5.15
$131.33K
Murphy Polly A.
20 Dec 2021
Director
Buy
12,000
$8.57
$102.80K
BERGER FRANKLIN M
3 Nov 2020
Director
Buy
41,666
$24.00
$999.98K
Hack Andrew A. F.
3 Nov 2020
Director
Buy indirect
250,000
$24.00
$6.00M
Rock Springs Capital Management LP
3 Nov 2020
10% owner
Buy indirect
7,292
$24.00
$175.01K
Rock Springs Capital Management LP
3 Nov 2020
10% owner
Buy indirect
242,708
$24.00
$5.82M

What was left out

Form 4 filings counted 106
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 18,047,437
Sales filed before the plan box existed 2
History held since 30 Oct 2020